EATG » Access

Access

Drug buyers’ clubs aim to tackle HIV prevention ‘crisis’

LONDON - A new generation of drug buyers' clubs like those set up at the height of the AIDS epidemic is seeking to combat a "crisis" in preventing new HIV…

FDA announces pilot program with WHO to expedite review of HIV drug applications

“Since the President’s Emergency Plan for AIDS Relief (PEPFAR) was launched 15 years ago to battle the global HIV/AIDS epidemic, more than 17 million lives have been saved and currently…

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

Paris, 5 December 2018 – Six organisations, including Médecins Sans Frontières (MSF), have just appealed the European Patent Office’s September decision to uphold US pharmaceutical corporation Gilead Science’s patent on the…

Pharmaceutical corporations failing children with HIV

MSF criticises pharma for dragging feet on developing HIV drugs for children Geneva, 29 November 2018—Ahead of a Vatican City meeting on scaling up HIV diagnosis and treatment for children,…

PEPFAR, launched as an emergency response to AIDS, has built a bridge to the future

Just 15 years ago, in a historic act of global humanitarian leadership, President George W. Bush proposed in his 2003 State of the Union address the creation of the President’s Emergency Plan…

Eastern Europe and Central Asia adopt statement on fighting infectious diseases

MINSK, 22 November (BelTA) – The international statement on expanding access to affordable and quality assured medicines and diagnostics will help coordinate efforts of Eastern Europe and Central Asia (EECA)…

2018 Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. Amsterdam, the Netherlands, 20 November…

HIV and TB treatment at risk as countries gradually lose Global Fund support

-- Low- and middle-income countries receive donor support for HIV and TB drugs from the Global Fund, but are gradually losing this support -- Global Fund policies on countries that…

MPP signs licence with AbbVie to expand access to key hepatitis C treatment, glecaprevir/pibrentasvir

Important collaboration will ensure affordable hepatitis C treatment options in low- and middle-income countries. San Francisco, 12 November 2018 – The Medicines Patent Pool (MPP) has today announced a new,…

The EATG publishes its position paper on drugs policy

Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…

1 2 3 39